| Cdk2 knockout mice are viable C Berthet, E Aleem, V Coppola, L Tessarollo, P Kaldis Current biology 13 (20), 1775-1785, 2003 | 845 | 2003 |
| Cdc2–cyclin E complexes regulate the G1/S phase transition E Aleem, H Kiyokawa, P Kaldis Nature cell biology 7 (8), 831-836, 2005 | 497 | 2005 |
| Targeting cell cycle regulators in hematologic malignancies E Aleem, RJ Arceci Frontiers in cell and developmental biology 3, 16, 2015 | 163 | 2015 |
| Cell cycle sibling rivalry: Cdc2 versus Cdk2 P Kaldis, E Aleem Cell cycle 4 (11), 1491-1494, 2005 | 129 | 2005 |
| Dependence of cisplatin-induced cell death in vitro and in vivo on cyclin-dependent kinase 2 PM Price, F Yu, P Kaldis, E Aleem, RL Safirstein, J Megyesi Journal of the American Society of Nephrology 17 (9), 2434-2442, 2006 | 124 | 2006 |
| IL-7 promotes T cell proliferation through destabilization of p27Kip1 WQ Li, Q Jiang, E Aleem, P Kaldis, AR Khaled, SK Durum The Journal of experimental medicine 203 (3), 573-582, 2006 | 112 | 2006 |
| β-Glucans and their applications in cancer therapy: focus on human studies E Aleem Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2013 | 98 | 2013 |
| Upregulation of the insulin receptor and type I insulin-like growth factor receptor are early events in hepatocarcinogenesis E Aleem, D Nehrbass, F Klimek, D Mayer, P Bannasch Toxicologic pathology 39 (3), 524-543, 2011 | 82 | 2011 |
| Cdk2 as a master of S phase entry: fact or fake? E Aleem, C Berthet, P Kaldis Cell Cycle 3 (1), 34-36, 2004 | 63 | 2004 |
| Schizophyllan inhibits the development of mammary and hepatic carcinomas induced by 7, 12 dimethylbenz (α) anthracene and decreases cell proliferation: comparison with tamoxifen A Mansour, A Daba, N Baddour, M El-Saadani, E Aleem Journal of cancer research and clinical oncology 138, 1579-1596, 2012 | 62 | 2012 |
| Nanoparticle-mediated cancer cell therapy: Basic science to clinical applications J Verma, C Warsame, RK Seenivasagam, NK Katiyar, E Aleem, S Goel Cancer and Metastasis Reviews 42 (3), 601-627, 2023 | 55 | 2023 |
| Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells R Bista, DW Lee, OB Pepper, DO Azorsa, RJ Arceci, E Aleem Journal of Experimental & Clinical Cancer Research 36, 1-14, 2017 | 55 | 2017 |
| Serum IGFBP‑3 is a more effective predictor than IGF‑1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection E Aleem, A Elshayeb, N Elhabachi, AR Mansour, A Gowily, A Hela Oncology letters 3 (3), 704-712, 2012 | 49 | 2012 |
| Cdk2 and Cdk4 activities are dispensable for tumorigenesis caused by the loss of p53 VC Padmakumar, E Aleem, C Berthet, MB Hilton, P Kaldis Molecular and cellular biology 29 (10), 2582-2593, 2009 | 45 | 2009 |
| PRKAR1A inactivation leads to increased proliferation and decreased apoptosis in human B lymphocytes AJ Robinson-White, WW Leitner, E Aleem, P Kaldis, I Bossis, CA Stratakis Cancer research 66 (21), 10603-10612, 2006 | 45 | 2006 |
| Nuclear insulin-like growth factor 1 receptor phosphorylates proliferating cell nuclear antigen and rescues stalled replication forks after DNA damage A Waraky, Y Lin, D Warsito, F Haglund, E Aleem, O Larsson Journal of Biological Chemistry 292 (44), 18227-18239, 2017 | 39 | 2017 |
| Picropodophyllin causes mitotic arrest and catastrophe by depolymerizing microtubules via insulin-like growth factor-1 receptor-independent mechanism A Waraky, K Akopyan, V Parrow, T Strömberg, M Axelson, L Abrahmsén, ... Oncotarget 5 (18), 8379, 2014 | 29 | 2014 |
| CDK2 is required by MYC to induce apoptosis D Deb-Basu, E Aleem, P Kaldis, DW Felsher Cell Cycle 5 (12), 1342-1347, 2006 | 26 | 2006 |
| Mouse models of cell cycle regulators: new paradigms E Aleem, P Kaldis Cell Cycle Regulation, 271-328, 2006 | 26 | 2006 |
| Induction of leukaemia in chloramphenicol-treated toads. AEA el-Mofty MM, Abdelmeguid NE, Sadek IA, Essawy AE East Mediterr Health J. 6 (5-6), 1026-34., 2000 | 26* | 2000 |
Philipp KaldisLund University, Department of Clinical Sciences, Clinical Research Centre (CRC), Sweden and LundEmail verificata su med.lu.se
